dividend growth

Delta Air Lines surged after beating Q1 earnings estimates with record $15.85B revenue, while Iran ceasefire eased geopolitical risks. Analysts target $96-$102.50 by mid-year.

Three dividend stocks—Enterprise Products Partners, Realty Income, and Procter & Gamble—offer 28 to 70 years of consecutive dividend growth for reliable passive income.

Enterprise Products Partners and Realty Income have raised dividends 216 times combined since 1994, offering yields of 5.8% and 5.2% respectively with exceptional reliability.

Three dividend aristocrats—Enterprise Products Partners, Realty Income, and Medtronic—offer attractive yields and decades-long dividend growth track records for income-seeking investors.

$SCHD delivers 3.3% dividend yield—triple the S&P 500—by selecting 100 financially strong companies with 10+ years dividend growth history, offering retirement investors accessible, low-cost income.

AbbVie maintains 10+ years of consecutive dividend increases despite Humira patent loss, buoyed by blockbuster drugs Skyrizi and Rinvoq projected to reach $50B by 2030.

Realty Income ($O) offers 57 years of monthly dividends with 114 consecutive quarterly increases at 4.2% CAGR, yielding 5.2%.

Buffett's core holdings in Apple, American Express, and Coca-Cola exemplify his forever-stock philosophy through durable competitive moats and consistent earnings growth.

Tractor Supply stock down 20% after weak earnings, but defensive business model centered on non-discretionary farm and pet products suggests oversold conditions.

Merck acquires Terns Pharmaceutical for $6.7B to expand cancer pipeline with oral BCR-ABL1 inhibitor, targeting $70B commercial opportunity by mid-2030s.

Valero Energy ($VLO) surged 45% YTD on tight refining capacity, 98% utilization, and strong Q4 results. Analysts raised targets to $290, suggesting sustainable outperformance.

Tractor Supply leverages 40M loyalty members and essential product focus to weather 25% stock decline amid consumer discretionary pullback.

NNN REIT's 36-year dividend streak exceeds Realty Income's 31-year streak, and its smaller $7.9B scale enables more selective acquisitions and a higher 5.7% yield.

Market fear and elevated cash hoards create contrarian opportunities in dividend-growth stocks like Aflac, trading 10% below 52-week highs with 43 consecutive dividend increases.

Texas Instruments trades at attractive valuations with a 3% dividend yield and 22 consecutive years of dividend increases, positioning it as a future Dividend King.

Johnson & Johnson maintains 63-year dividend growth streak, supported by strong pharmaceutical pipeline, $100B revenue projection, and AAA credit rating despite healthcare regulatory pressures.

Ball and Crown report record 2025 results with strong cash flow. Analysts see 15-25% upside potential amid risk-off market conditions.

Waste Management and Gilead Sciences offer attractive dividend-growth opportunities as pullbacks from Middle East tensions create entry points for AI-driven productivity investors.

Schwab's Dividend ETF added UnitedHealth and Abbott while removing AbbVie, boosting healthcare allocation to 18.9% and increasing average dividend growth rates.

PayPoint reports record FY26 results and announces major reorganization into four business units. Company executing £23.8M share buyback while targeting 30% capital reduction by FY28.